Australian researchers find unique way to combat dengue

Image
IANS Melbourne
Last Updated : Apr 01 2015 | 7:22 AM IST

Australian researchers have come up with a unique way of preventing the spread of the dengue virus, a mosquito-borne disease that currently has no approved vaccine, according to a media report on Wednesday.

The University of Melbourne-led team of researchers discovered that mosquitoes, exposed to an insect bacterium called Wolbachia, were unable to acquire the dengue virus from infected humans, Xinhua reported.

Cameron Simmons, from the department of microbiology and immunology at the University of Melbourne, and the Peter Doherty Institute for Infection and Immunity, said on Wednesday that the discovery could mean a drastic reduction in the cases of dengue.

"We did a 'real world' experiment and allowed mosquitoes infected with Wolbachia and uninfected mosquitoes to feed on the blood of Vietnamese dengue patients," Simmons said.

"Our team then measured how efficiently Wolbachia blocked dengue virus infection of the mosquito body and saliva, which in turn stops them spreading the virus between humans."

The research concluded that in areas where the rate of dengue infection was low, exposing mosquitos to Wolbachia could stop all cases of dengue fever.

"We found that Wolbachia could eliminate dengue transmission in locations where the intensity of transmission is low or moderate," Simmons said.

"In high transmission settings, Wolbachia would also cause a significant reduction in transmission."

Wolbachia has been introduced in the tropical Australian cities of Townsville and Cairns, in the northern state of Queensland, and researchers expect the number of dengue infections in those centres to be drastically lower than in previous years.

Dengue fever, a viral infection found in 110 countries, spreads in tropical climates, causing flu-like symptoms such as headache and joint pain.

It is a widespread public health problem in Asia and Latin America, with research suggesting that more than 100 million cases are diagnosed globally every year.

"Our results will enable policy makers in dengue-affected countries to make informed decisions on Wolbachia when allocating scarce resources to dengue control," Simmons said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 01 2015 | 7:16 AM IST

Next Story